Recombinant Chlamydia trachomatis serovar L2 Elongation factor Tu (tuf)

Shipped with Ice Packs
In Stock

Description

Functional Roles in Chlamydia trachomatis Development

EF-Tu is dynamically regulated during the chlamydial developmental cycle:

  • Replicative Phase (Reticulate Bodies, RBs): EF-Tu is highly abundant in RBs, supporting rapid protein synthesis for bacterial replication .

  • Infectious Phase (Elementary Bodies, EBs): Lower EF-Tu levels correlate with reduced metabolic activity in EBs .

  • Persistent Forms (Aberrant RBs, ARBs): Under interferon-γ stress, EF-Tu expression persists, enabling survival despite host immune pressure .

Table 1: EF-Tu Abundance Across Growth Forms (Proteomic Data)3

Growth FormEF-Tu Abundance (% Total Protein)Key Function
Reticulate Body2.1%Protein synthesis, replication
Elementary Body0.8%Structural maintenance
Aberrant RB1.9%Stress adaptation

Genomic Quantification

The tuf gene serves as a reliable reference in qPCR for quantifying chlamydial genomic DNA (gDNA) due to its single-copy nature and stable expression .

Reporter Systems

The tuf ribosome-binding site (RBS) enhances heterologous gene expression in C. trachomatis. For example:

  • A GFP reporter plasmid using the tuf RBS achieved detectable fluorescence in C. trachomatis inclusions by 16 hours post-infection .

  • Dual-reporter systems (e.g., GFP/mCherry) leverage tuf RBS for normalization in promoter activity studies .

Table 2: Key Studies Utilizing EF-Tu or tuf

ApplicationFindingsSource
qPCR Standardizationtuf primers enabled accurate gDNA quantification during RB replication
Reporter Gene Expressiontuf RBS increased GFP expression efficiency by 3.5-fold
Proteomic ProfilingEF-Tu abundance correlated with RB metabolic activity

Implications for Pathogenesis and Therapeutics

  • Antibiotic Resistance: EF-Tu’s interaction with ribosomes may influence responses to antibiotics like moxifloxacin, as tuf expression stability affects bacterial recovery under drug pressure .

  • Diagnostic Potential: EF-Tu’s immunogenicity makes it a candidate for serodiagnostic assays targeting chlamydial infections .

Future Directions

  • Structural Studies: Resolving EF-Tu’s 3D conformation could inform GTPase inhibitor design.

  • Persistent Infections: Elucidating EF-Tu’s role in ARB survival may yield strategies to disrupt chronic infections .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins ship with standard blue ice packs. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tuf; CTL0574Elongation factor Tu; EF-Tu
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-394
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B)
Target Names
tuf
Target Protein Sequence
SKETFQRNK PHINIGTIGH VDHGKTTLTA AITRTLSGDG LADFRDYSSI DNTPEEKARG ITINASHVEY ETANRHYAHV DCPGHADYVK NMITGAAQMD GAILVVSATD GAMPQTKEHI LLARQVGVPY IVVFLNKIDM ISEEDAELVD LVEMELAELL EEKGYKGCPI IRGSALKALE GDAAYIEKVR ELMQAVDDNI PTPEREIDKP FLMPIEDVFS ISGRGTVVTG RIERGIVKVS DKVQLVGLRD TKETIVTGVE MFRKELPEGR AGENVGLLLR GIGKNDVERG MVVCLPNSVK PHTRFKCAVY VLQKEEGGRH KPFFTGYRPQ FFFRTTDVTG VVTLPEGVEM VMPGDNVEFE VQLISPVALE EGMRFAIREG GRTIGAGTIS KIIA
Uniprot No.

Target Background

Function
This protein promotes GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.
Database Links

KEGG: ctb:CTL0574

Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Elongation factor Tu (tuf) in Chlamydia trachomatis and what is its function?

Elongation factor Tu (tuf) is a highly conserved bacterial protein essential for protein synthesis in C. trachomatis. It functions during the elongation phase of translation by delivering aminoacyl-tRNAs to the ribosome. The protein forms a ternary complex with GTP and aminoacyl-tRNA that interacts with the ribosome during translation. Following correct codon-anticodon pairing, GTP is hydrolyzed to GDP, and EF-Tu is released from the ribosome.

The tuf protein in C. trachomatis consists of 394 amino acids, as indicated in available product information . The amino acid sequence includes GTP-binding domains and regions responsible for interacting with aminoacyl-tRNAs and the ribosome. Given C. trachomatis' nature as an obligate intracellular pathogen with a unique developmental cycle, the tuf protein is crucial for understanding the organism's biology and pathogenesis.

How is recombinant C. trachomatis tuf protein expressed and purified for research applications?

Recombinant C. trachomatis tuf protein is typically expressed in E. coli expression systems, which provide high yield and relatively straightforward purification protocols. Commercial preparations predominantly use E. coli as the expression host .

The standard expression and purification process includes:

  • Cloning the full-length tuf gene (encoding all 394 amino acids) into an appropriate expression vector

  • Transforming the construct into a suitable E. coli strain optimized for protein expression

  • Inducing protein expression under controlled conditions

  • Cell lysis followed by multi-step purification

Purification typically employs:

  • Affinity chromatography using tags such as His-tag or SUMO-tag systems

  • Size exclusion chromatography for further purification

  • SDS-PAGE verification (aiming for >85-90% purity)

  • Final preparation as either lyophilized powder or in stabilizing buffer

This process yields highly pure protein suitable for various research applications while maintaining the structural and functional integrity of the native tuf protein.

What are the structural characteristics of tuf protein from C. trachomatis serovar L2?

The tuf protein from C. trachomatis serovar L2 is a GTP-binding protein with several conserved structural domains. Based on the amino acid sequence available , key structural features include:

Three main domains:

  • Domain I: N-terminal domain containing GTP/GDP binding sites and catalytic center

  • Domain II: Middle domain involved in aminoacyl-tRNA interactions

  • Domain III: C-terminal domain contributing to protein stability and function

Key functional motifs include:

  • G1 motif (GXXXXGK) for phosphate binding

  • G2 motif (DXXG) involved in Mg²⁺ coordination

  • G3 motif (NKXD) for base specificity

  • G4 motif (NXXA) for guanine recognition

The full sequence of 394 amino acids forms a protein with a molecular weight of approximately 43-45 kDa. The protein undergoes significant conformational changes during its functional cycle, transitioning between GTP-bound (active) and GDP-bound (inactive) states.

How can researchers effectively study tuf gene regulation in C. trachomatis?

Studying tuf gene regulation in C. trachomatis requires specialized approaches due to the organism's obligate intracellular lifestyle. Several methodologies have proven effective:

  • Promoter analysis: The tuf gene in C. trachomatis is regulated by σ66-specific promoters, which often contain -35 (TTGACA) and -10 (TATAAT) consensus elements similar to E. coli σ70 promoters with an optimal ~17-bp spacer . Researchers can analyze these promoter elements using:

    • In silico analyses with tools like MotifSearch to identify promoter sequences

    • Reporter gene assays to assess promoter strength

    • DNA-protein interaction studies to identify regulatory factors

  • Transcriptional analysis:

    • RT-qPCR to quantify tuf transcript levels during different developmental stages

    • RNA-seq to analyze tuf expression in context of the entire transcriptome

    • In vitro transcription assays using hybrid systems with σ66-RNA polymerase

  • Developmental regulation studies:

    • Time-course experiments following infection to track tuf expression

    • Analysis of tuf expression in response to stress conditions, such as exposure to cytokines like TNF-α

Understanding tuf regulation provides important insights into how C. trachomatis modulates its translational machinery during different stages of its developmental cycle.

What experimental methods are most effective for studying tuf function in C. trachomatis?

Due to the obligate intracellular nature of C. trachomatis, specialized experimental approaches are required to study tuf function:

  • In vitro biochemical assays:

    • GTP binding and hydrolysis assays with purified recombinant tuf

    • Aminoacyl-tRNA binding studies

    • Ribosome interaction analyses

  • Cell culture-based approaches:

    • Infection models using appropriate host cells (e.g., HEp-2 cells)

    • Immunofluorescence microscopy to track tuf localization

    • Analysis of tuf expression during the developmental cycle

  • Hybrid systems:

    • Reconstituted transcription/translation systems combining E. coli components with C. trachomatis factors

    • E. coli complementation studies to assess tuf functionality

  • Genetic approaches:

    • Transformation with fluorescent-tagged tuf constructs

    • Site-directed mutagenesis to investigate structure-function relationships

  • Comparative genomics:

    • Analysis of tuf sequence conservation across Chlamydia serovars

    • Identification of unique structural features compared to tuf from other bacteria

These methodologies allow researchers to overcome the challenges of working with this difficult-to-cultivate pathogen while gaining valuable insights into tuf function.

How does tuf expression change during the developmental cycle of C. trachomatis?

The expression of tuf during the C. trachomatis developmental cycle follows a pattern that reflects the metabolic needs of the organism:

  • Early phase (0-12 hours post-infection):

    • Following entry, elementary bodies (EBs) differentiate into reticulate bodies (RBs)

    • tuf expression increases to support the growing translational needs

    • Promoter activation is likely mediated by σ66-dependent transcription

  • Middle phase (12-24 hours):

    • Peak metabolic activity and protein synthesis in RBs

    • Highest levels of tuf expression to support active translation

    • Expression regulated through specific promoter elements

  • Late phase (24-48+ hours):

    • RBs begin converting back to EBs

    • Gradual decrease in tuf expression as metabolic activity declines

    • Differential regulation as the bacterium prepares for release and new infection

The timing of peak tuf expression may be manipulated experimentally by factors that affect the developmental cycle, such as cytokines like TNF-α, which has been shown to inhibit C. trachomatis growth even when added up to 12 hours after infection .

How is recombinant tuf protein used in quality control for C. trachomatis diagnostic assays?

Recombinant C. trachomatis tuf protein serves as a valuable component in quality control materials for diagnostic assays, particularly nucleic acid amplification tests (NAATs):

  • Standard material preparation:

    • Recombinant tuf protein provides consistent, reproducible control material

    • Can be used to establish standard curves for quantitative assays

    • Serves as positive control in immunoassays

  • Quality control material applications:

    • Method establishment and validation for CT NAATs

    • Internal quality control to ensure assay performance

    • External quality assessment programs

  • Advantages as quality control material:

    • High purity (>85% by SDS-PAGE)

    • Stable characteristics when properly stored

    • Defined composition without biological variability

    • Availability without need to culture C. trachomatis

  • Implementation approaches:

    • Integration into diagnostic workflows as positive controls

    • Use in proficiency testing programs

    • Application in assay development and optimization

The use of recombinant proteins like tuf represents a significant improvement over traditional quality control materials derived from cultured organisms, offering greater reproducibility and stability .

What is the relationship between tuf and antibiotic susceptibility in C. trachomatis?

The relationship between tuf and antibiotic susceptibility in C. trachomatis involves several interconnected mechanisms:

  • Direct antibiotic interactions:

    • In some bacteria, EF-Tu is a target for antibiotics like kirromycin

    • Structural variations in C. trachomatis tuf may influence binding of such antibiotics

    • Point mutations could potentially confer resistance

  • Translational effects on resistance determinants:

    • As a key component of protein synthesis, tuf indirectly affects expression of all bacterial proteins

    • Modulation of tuf activity can influence production of proteins involved in antibiotic resistance

    • Translational efficiency impacts the bacterium's ability to respond to antibiotic stress

  • Developmental stage considerations:

    • Differential expression of tuf across developmental stages correlates with varying antibiotic susceptibilities

    • Elementary bodies (EBs) with reduced tuf activity are generally more resistant to antibiotics targeting protein synthesis

    • Reticulate bodies (RBs) with high tuf activity are typically more susceptible

  • Persistent infection mechanisms:

    • Under stress conditions, such as exposure to cytokines like TNF-α , C. trachomatis can enter a persistent state

    • This state involves altered tuf expression and reduced translational activity

    • Persistence is associated with reduced susceptibility to certain antibiotics

Research examining these relationships typically employs experimental approaches such as comparative analysis of antibiotic-resistant isolates and assessment of tuf expression under antibiotic pressure.

How can researchers differentiate between the functions of tuf in C. trachomatis and other bacterial species?

Differentiating the functions of tuf in C. trachomatis from those in other bacteria requires a multifaceted approach:

  • Comparative sequence analysis:

    • Alignment of tuf sequences across bacterial species

    • Identification of unique residues in C. trachomatis tuf

    • Evolutionary analysis to identify selectively constrained regions

  • Structural biology approaches:

    • Crystallography or cryo-EM of C. trachomatis tuf

    • Comparison with structures from model organisms

    • Identification of structural differences that may relate to functional variations

  • Heterologous expression studies:

    • Complementation experiments in E. coli tuf mutants

    • Assessment of functional interchangeability

    • Identification of species-specific interactions

  • Promoter regulation comparison:

    • Analysis of the unique σ66-dependent regulation in C. trachomatis

    • Comparison with regulatory mechanisms in other bacteria

    • Evaluation of developmental stage-specific expression patterns

  • Protein interaction networks:

    • Identification of C. trachomatis-specific tuf-interacting partners

    • Comparison with interaction networks in model organisms

    • Discovery of unique moonlighting functions

This comparative approach reveals how tuf function has been adapted to the unique intracellular lifestyle and developmental cycle of C. trachomatis, providing insights into bacterial evolution and specialization.

What role does tuf play in host-pathogen interactions during C. trachomatis infection?

While primarily known for its role in translation, tuf may contribute to host-pathogen interactions during C. trachomatis infection through several mechanisms:

  • Potential moonlighting functions:

    • In other bacteria, tuf has been shown to function beyond translation

    • Possible roles in adhesion to host cells or extracellular matrix

    • Potential interactions with host cytoskeletal components

  • Immune recognition:

    • As a highly conserved bacterial protein, tuf may be recognized by host pattern recognition receptors

    • May contribute to innate immune activation

    • Could serve as a target for adaptive immune responses

  • Modulation by host factors:

    • Host cytokines like TNF-α can inhibit C. trachomatis growth , potentially affecting tuf function

    • The synergistic effect of TNF-α with gamma interferon may involve translational regulation

    • Host-induced stress may alter tuf expression patterns

  • Developmental regulation in response to host environment:

    • tuf expression changes during the developmental cycle in response to host conditions

    • May participate in sensing environmental cues within the inclusion

    • Could contribute to decisions regarding persistence or continued development

  • Experimental approaches to investigate these roles:

    • Co-immunoprecipitation studies to identify host interaction partners

    • Localization studies during different infection stages

    • Assessment of immune responses to recombinant tuf protein

Understanding these non-canonical roles of tuf provides deeper insights into the complex relationship between C. trachomatis and its host cells.

What are the optimal storage and handling conditions for recombinant C. trachomatis tuf protein?

Proper storage and handling of recombinant C. trachomatis tuf protein is critical for maintaining its structural integrity and functional properties:

FormStorage TemperatureShelf LifeRecommendations
Lyophilized-20°C to -80°C12 monthsKeep sealed, protect from moisture
Reconstituted-20°C to -80°C6 monthsAdd 5-50% glycerol, store in aliquots
Working solution4°CUp to 1 weekAvoid repeated freeze-thaw cycles

Reconstitution protocol:

  • Briefly centrifuge the vial before opening to collect material at the bottom

  • Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 50% for optimal stability

  • Prepare small working aliquots to avoid repeated freeze-thaw cycles

Additional considerations:

  • Avoid exposing the protein to extreme pH conditions

  • Minimize exposure to proteases

  • For long-term experiments, verify protein activity periodically

  • Consider the addition of reducing agents if the protein contains cysteines

Following these guidelines ensures maximum stability and consistency in experimental results when working with recombinant tuf protein .

What are the most promising future research directions involving C. trachomatis tuf?

Several promising research directions involving C. trachomatis tuf offer potential for significant advances:

  • Structural biology:

    • High-resolution structures of C. trachomatis tuf in different nucleotide-bound states

    • Comparative analysis with tuf from other bacteria

    • Structure-based drug design targeting unique features of chlamydial tuf

  • Systems biology:

    • Integration of tuf function into comprehensive models of C. trachomatis development

    • Network analysis of tuf interactions throughout the developmental cycle

    • Computational modeling of translational efficiency under different conditions

  • Diagnostic applications:

    • Development of novel quality control materials based on recombinant tuf

    • Tuf-targeted diagnostic approaches with improved sensitivity

    • Point-of-care testing utilizing tuf-specific detection

  • Therapeutic targets:

    • Identification of compounds that specifically inhibit C. trachomatis tuf

    • Investigation of synergistic effects between tuf inhibitors and immune modulators like TNF-α

    • Development of peptides that disrupt specific tuf interactions

  • Vaccine development:

    • Assessment of tuf-based subunit vaccines

    • Evaluation of immune responses to conserved vs. variable tuf epitopes

    • Investigation of tuf as a carrier protein for other antigens

  • Evolutionary studies:

    • Analysis of tuf conservation across Chlamydia species and strains

    • Investigation of tuf adaptation to the intracellular lifestyle

    • Identification of selective pressures on tuf during host switching events

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.